Hemolytic uremic syndrome following the infusion of oxaliplatin: case report
2006
Hemolytic Uremic Syndrome After Oxaliplatin Chemotherapy
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Dahabreh Issa, Tsoutsos George, Tseligas Dimitrios, Janinis Dimitrios
Primary Institution: Athens Medical Center, Marousi, Greece
Conclusion
Hemolytic-uremic syndrome may occur as a rare complication of oxaliplatin-based chemotherapy, requiring careful monitoring by clinicians.
Supporting Evidence
- The patient developed hemolytic-uremic syndrome after the 4th cycle of chemotherapy.
- Chemotherapy was discontinued, and the patient was treated with IV hydration and corticosteroids.
- The patient fully recovered and remained disease-free one year later.
Takeaway
A man got sick after his cancer treatment with a drug called oxaliplatin, but he got better after stopping the treatment and receiving care.
Methodology
Case report detailing the patient's treatment and recovery process.
Limitations
Only one case is reported, limiting generalizability.
Participant Demographics
52-year-old male with a history of non-insulin-dependent diabetes mellitus.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website